Global Cancer Technology

Developing a novel drug to treat glioblastoma brain cancer and triple-negative breast cancer

https://wefunder.com/global.cancer.technology

Total raised on Wefunder: 0

Total investors: 0

Quick facts

  • We have shown that our drug can make glioblastoma tumors completely disappear in lab mice
  • Research partners are Baylor University, Brown, University of Colorado , Mayo clinic and others
  • We have been prove equal to better than a similar drug entering a phase 111 clinical trial
  • Research will soon show us as the leading promising drug for children's glioblastoma, or DIPG
  • Preclinical studies have shown us to outperform Alpelisib, a breast cancer FDA-approved drug
  • Outstanding Scientific and Business advisory board

Team profiles

Featured investor profiles

Global Cancer Technology

Developing a novel drug to treat glioblastoma brain cancer and triple-negative breast cancer

EARLY BIRD TERMS: $2,699,998,400 LEFT

$1,600

of a $100,000 goal
INVESTMENT TERMS
Priced Round
 $30M  $27M pre-money valuation
Early Bird Bonus: The first $3B of investments will be at a $27M pre-money valuation
$1K

Highlights

1
We have shown that our drug can make glioblastoma tumors completely disappear in lab mice
2
Research partners are Baylor University, Brown, University of Colorado , Mayo clinic and others
3
We have been prove equal to better than a similar drug entering a phase 111 clinical trial
4
Research will soon show us as the leading promising drug for children's glioblastoma, or DIPG

Related company links

Team

Memo
































Downloads

Overview